Avantor, Inc.

AVTR Healthcare Medical Instruments & Supplies

Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 33.3%, free cash flow grew 12.7% and total debt fell 12.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

16.42 0.33 +2.05%
Market cap
$10.9B
P/E
0.0×
Fwd P/E
25.5×
Dividend yield
—
F-score
4/9
Altman Z
1.55
Beneish M
−2.91
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

4 4 5 5
ROE
(1.48%) (9.20%) (9.44%) (9.70%)
ROA
(0.67%) (4.44%) (4.60%) (4.74%)
ROIC
1.81% (1.68%) (2.01%) (2.09%)
Return on Tangible Assets
(5.47%) (28.83%) (30.58%) (31.20%)
Average Days of Receivables
59.82 59.86 61.54 63.36
Free Cash Flow per Share
0.77 0.73 0.65 0.67
Free Cash Flow
523.60 495.00 438.90 454.70
Capital Expenditures
(120.80) (128.80) (134.30) (142.30)
Other line items
Cash ROIC
5.41% 5.01% 4.53% 4.72%
Accounts Receivable Turnover
6.07 6.21 5.95 5.73
Accounts Payable Turnover
6.44 6.28 6.28 6.16
Inventory Turnover
5.58 5.70 5.70 5.56
Average Days of Payables
57.41 61.35 60.37 60.65
Days of Inventory on Hand
66.04 67.68 66.51 67.62
Tax Rate
(2.32) 0.20 0.17 0.22
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
23.95% 24.35% 24.56% 24.37%
Share Based Compensation of Revenue
0.70% 0.71% 0.65% 0.65%
Interest Coverage
1.52 (1.45) (1.72) (1.81)
Operating CF/Net income
(7.84) (1.18) (1.04) (1.03)
Depreciation/Fixed assets
0.55 0.55 0.55 0.55
Capex/Depreciation
(0.29) (0.31) (0.32) (0.33)
Revenue per Share
9.65 9.63 9.70 9.70
Operating CF per Share
0.95 0.92 0.85 0.88
Capex per Share
(0.18) (0.19) (0.20) (0.21)
Capex to Sales
0.02 0.02 0.02 0.02

Fold the line items

Columns are period end dates